146 related articles for article (PubMed ID: 30423128)
1. Pharmacokinetics and In Vivo Efficacy of Pyrazolopyrimidine, Pyrrolopyrimidine, and 5-Aminopyrazole-4-Carboxamide Bumped Kinase Inhibitors against Toxoplasmosis.
Hulverson MA; Bruzual I; McConnell EV; Huang W; Vidadala RSR; Choi R; Arnold SLM; Whitman GR; McCloskey MC; Barrett LK; Rivas KL; Scheele S; DeRocher AE; Parsons M; Ojo KK; Maly DJ; Fan E; Van Voorhis WC; Doggett JS
J Infect Dis; 2019 Apr; 219(9):1464-1473. PubMed ID: 30423128
[TBL] [Abstract][Full Text] [Related]
2. Bumped kinase inhibitor 1294 treats established Toxoplasma gondii infection.
Doggett JS; Ojo KK; Fan E; Maly DJ; Van Voorhis WC
Antimicrob Agents Chemother; 2014 Jun; 58(6):3547-9. PubMed ID: 24687502
[TBL] [Abstract][Full Text] [Related]
3. 1NM-PP1 treatment of mice infected with Toxoplasma gondii.
Sugi T; Kato K; Kobayashi K; Kurokawa H; Takemae H; Gong H; Recuenco FC; Iwanaga T; Horimoto T; Akashi H
J Vet Med Sci; 2011 Oct; 73(10):1377-9. PubMed ID: 21685719
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Calcium Dependent Protein Kinase 1 (CDPK1) by Pyrazolopyrimidine Analogs Decreases Establishment and Reoccurrence of Central Nervous System Disease by Toxoplasma gondii.
Rutaganira FU; Barks J; Dhason MS; Wang Q; Lopez MS; Long S; Radke JB; Jones NG; Maddirala AR; Janetka JW; El Bakkouri M; Hui R; Shokat KM; Sibley LD
J Med Chem; 2017 Dec; 60(24):9976-9989. PubMed ID: 28933846
[TBL] [Abstract][Full Text] [Related]
5. Comparative assessment of the effects of bumped kinase inhibitors on early zebrafish embryo development and pregnancy in mice.
Anghel N; Winzer PA; Imhof D; Müller J; Langa X; Rieder J; Barrett LK; Vidadala RSR; Huang W; Choi R; Hulverson MA; Whitman GR; Arnold SL; Van Voorhis WC; Ojo KK; Maly DJ; Fan E; Hemphill A
Int J Antimicrob Agents; 2020 Sep; 56(3):106099. PubMed ID: 32707170
[TBL] [Abstract][Full Text] [Related]
6. Treatment with Bumped Kinase Inhibitor 1294 Is Safe and Leads to Significant Protection against Abortion and Vertical Transmission in Sheep Experimentally Infected with Toxoplasma gondii during Pregnancy.
Sánchez-Sánchez R; Ferre I; Re M; Ramos JJ; Regidor-Cerrillo J; Pizarro Díaz M; González-Huecas M; Tabanera E; Benavides J; Hemphill A; Hulverson MA; Barrett LK; Choi R; Whitman GR; Ojo KK; Van Voorhis WC; Ortega-Mora LM
Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31061151
[TBL] [Abstract][Full Text] [Related]
7. Pyrrolopyrimidine Bumped Kinase Inhibitors for the Treatment of Cryptosporidiosis.
Hulverson MA; Choi R; Vidadala RSR; Whitman GR; Vidadala VN; Ojo KK; Barrett LK; Lynch JJ; Marsh K; Kempf DJ; Maly DJ; Van Voorhis WC
ACS Infect Dis; 2021 May; 7(5):1200-1207. PubMed ID: 33565854
[TBL] [Abstract][Full Text] [Related]
8. Toxoplasma gondii calcium-dependent protein kinase 1 is a target for selective kinase inhibitors.
Ojo KK; Larson ET; Keyloun KR; Castaneda LJ; Derocher AE; Inampudi KK; Kim JE; Arakaki TL; Murphy RC; Zhang L; Napuli AJ; Maly DJ; Verlinde CL; Buckner FS; Parsons M; Hol WG; Merritt EA; Van Voorhis WC
Nat Struct Mol Biol; 2010 May; 17(5):602-7. PubMed ID: 20436472
[TBL] [Abstract][Full Text] [Related]
9. Development of 5-Aminopyrazole-4-carboxamide-based Bumped-Kinase Inhibitors for Cryptosporidiosis Therapy.
Huang W; Hulverson MA; Choi R; Arnold SLM; Zhang Z; McCloskey MC; Whitman GR; Hackman RC; Rivas KL; Barrett LK; Ojo KK; Van Voorhis WC; Fan E
J Med Chem; 2019 Mar; 62(6):3135-3146. PubMed ID: 30830766
[TBL] [Abstract][Full Text] [Related]
10. Novel Molecules To Treat Chronic Central Nervous System Toxoplasmosis.
Kortagere S
J Med Chem; 2017 Dec; 60(24):9974-9975. PubMed ID: 29200288
[TBL] [Abstract][Full Text] [Related]
11. Optimizing Pyrazolopyrimidine Inhibitors of Calcium Dependent Protein Kinase 1 for Treatment of Acute and Chronic Toxoplasmosis.
Janetka JW; Hopper AT; Yang Z; Barks J; Dhason MS; Wang Q; Sibley LD
J Med Chem; 2020 Jun; 63(11):6144-6163. PubMed ID: 32420739
[TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of Sarcocystis neurona calcium-dependent protein kinase 1 for equine protozoal myeloencephalitis therapy.
Ojo KK; Dangoudoubiyam S; Verma SK; Scheele S; DeRocher AE; Yeargan M; Choi R; Smith TR; Rivas KL; Hulverson MA; Barrett LK; Fan E; Maly DJ; Parsons M; Dubey JP; Howe DK; Van Voorhis WC
Int J Parasitol; 2016 Dec; 46(13-14):871-880. PubMed ID: 27729271
[TBL] [Abstract][Full Text] [Related]
13. Toxoplasma Calcium-Dependent Protein Kinase 1 Inhibitors: Probing Activity and Resistance Using Cellular Thermal Shift Assays.
Scheele S; Geiger JA; DeRocher AE; Choi R; Smith TR; Hulverson MA; Vidadala RSR; Barrett LK; Maly DJ; Merritt EA; Ojo KK; Van Voorhis WC; Parsons M
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29555627
[TBL] [Abstract][Full Text] [Related]
14. Development of Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) inhibitors with potent anti-toxoplasma activity.
Johnson SM; Murphy RC; Geiger JA; DeRocher AE; Zhang Z; Ojo KK; Larson ET; Perera BG; Dale EJ; He P; Reid MC; Fox AM; Mueller NR; Merritt EA; Fan E; Parsons M; Van Voorhis WC; Maly DJ
J Med Chem; 2012 Mar; 55(5):2416-26. PubMed ID: 22320388
[TBL] [Abstract][Full Text] [Related]
15. Neospora caninum calcium-dependent protein kinase 1 is an effective drug target for neosporosis therapy.
Ojo KK; Reid MC; Kallur Siddaramaiah L; Müller J; Winzer P; Zhang Z; Keyloun KR; Vidadala RS; Merritt EA; Hol WG; Maly DJ; Fan E; Van Voorhis WC; Hemphill A
PLoS One; 2014; 9(3):e92929. PubMed ID: 24681759
[TBL] [Abstract][Full Text] [Related]
16. Potent and selective inhibitors of CDPK1 from
Zhang Z; Ojo KK; Vidadala R; Huang W; Geiger JA; Scheele S; Choi R; Reid MC; Keyloun KR; Rivas K; Siddaramaiah LK; Comess KM; Robinson KP; Merta PJ; Kifle L; Hol WG; Parsons M; Merritt EA; Maly DJ; Verlinde CL; Van Voorhis WC; Fan E
ACS Med Chem Lett; 2014 Jan; 5(1):40-44. PubMed ID: 24494061
[TBL] [Abstract][Full Text] [Related]
17. 5-Aminopyrazole-4-Carboxamide-Based Compounds Prevent the Growth of Cryptosporidium parvum.
Huang W; Choi R; Hulverson MA; Zhang Z; McCloskey MC; Schaefer DA; Whitman GR; Barrett LK; Vidadala RSR; Riggs MW; Maly DJ; Van Voorhis WC; Ojo KK; Fan E
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533246
[No Abstract] [Full Text] [Related]
18. A focused small-molecule screen identifies 14 compounds with distinct effects on Toxoplasma gondii.
Kamau ET; Srinivasan AR; Brown MJ; Fair MG; Caraher EJ; Boyle JP
Antimicrob Agents Chemother; 2012 Nov; 56(11):5581-90. PubMed ID: 22908155
[TBL] [Abstract][Full Text] [Related]
19. Bumped-Kinase Inhibitors for Cryptosporidiosis Therapy.
Hulverson MA; Vinayak S; Choi R; Schaefer DA; Castellanos-Gonzalez A; Vidadala RSR; Brooks CF; Herbert GT; Betzer DP; Whitman GR; Sparks HN; Arnold SLM; Rivas KL; Barrett LK; White AC; Maly DJ; Riggs MW; Striepen B; Van Voorhis WC; Ojo KK
J Infect Dis; 2017 Apr; 215(8):1275-1284. PubMed ID: 28329187
[TBL] [Abstract][Full Text] [Related]
20. [New pathogens and mode of action of azithromycin: Toxoplasma gondii].
Derouin F
Pathol Biol (Paris); 1995 Jun; 43(6):561-4. PubMed ID: 8539083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
